Phoenix Financial Ltd. 13D/13G Filings for Teva Pharmaceutical Industries Limited (TEVA)

Phoenix Financial Ltd. 13D and 13G filings for Teva Pharmaceutical Industries Limited:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-04-09
10:26 am
Purchase
2024-04-01 13G Teva Pharmaceutical Industries Limited
TEVA
Phoenix Financial Ltd. 54,144,997
4.830%
54,144,997increase
(New Position)
Filing